Blueprint Medicines Corp Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Blueprint Medicines Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Blueprint Medicines Corp for March 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 21 2018 | BPMC | Blueprint Medicine ... | Demetri George | Director | Sell | S | 99.06 | 1,200 | 118,872 | 6,439 | 7.6 K to 6.4 K (-15.71 %) |
Mar 21 2018 | BPMC | Blueprint Medicine ... | Demetri George | Director | Sell | S | 100.04 | 2,592 | 259,304 | 7,639 | 10.2 K to 7.6 K (-25.33 %) |
Mar 21 2018 | BPMC | Blueprint Medicine ... | Demetri George | Director | Sell | S | 100.88 | 1,700 | 171,496 | 10,231 | 11.9 K to 10.2 K (-14.25 %) |
Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 36.05 | 2,500 | 90,125 | 118,139 | |
Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 16.28 | 1,571 | 25,576 | 120,639 | |
Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 99.20 | 571 | 56,643 | 5,874 | 6.4 K to 5.9 K (-8.86 %) |
Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 100.02 | 1,200 | 120,024 | 6,445 | 7.6 K to 6.4 K (-15.70 %) |
Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 101.32 | 1,800 | 182,376 | 7,645 | 9.4 K to 7.6 K (-19.06 %) |
Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 102.19 | 500 | 51,095 | 9,445 | 9.9 K to 9.4 K (-5.03 %) |
Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 36.05 | 2,500 | 90,125 | 9,945 | 7.4 K to 9.9 K (+33.58 %) |
Mar 20 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 16.28 | 1,571 | 25,576 | 7,445 | 5.9 K to 7.4 K (+26.74 %) |
Mar 19 2018 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Option Exercise | M | 37.11 | 2,300 | 85,353 | 119,200 | |
Mar 19 2018 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Sell | S | 100.07 | 2,300 | 230,161 | 0 | 2.3 K to 0 (-100.00 %) |
Mar 19 2018 | BPMC | Blueprint Medicine ... | Dorsch Marion | Chief Scientific Of ... | Buy | M | 37.11 | 2,300 | 85,353 | 2,300 | 0 to 2.3 K |
Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Option Exercise | M | 1.87 | 20,000 | 37,400 | 975,034 | |
Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 88.17 | 1,300 | 114,621 | 0 | 1.3 K to 0 (-100.00 %) |
Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 89.07 | 2,284 | 203,436 | 1,300 | 3.6 K to 1.3 K (-63.73 %) |
Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 90.52 | 600 | 54,312 | 3,584 | 4.2 K to 3.6 K (-14.34 %) |
Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 91.66 | 4,100 | 375,806 | 4,184 | 8.3 K to 4.2 K (-49.49 %) |
Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 92.76 | 1,900 | 176,244 | 8,284 | 10.2 K to 8.3 K (-18.66 %) |
Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 93.89 | 3,794 | 356,219 | 10,184 | 14 K to 10.2 K (-27.14 %) |
Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Sell | S | 94.79 | 6,022 | 570,825 | 13,978 | 20 K to 14 K (-30.11 %) |
Mar 06 2018 | BPMC | Blueprint Medicine ... | Albers Jeffrey W. | CEO and President | Buy | M | 1.87 | 20,000 | 37,400 | 20,000 | 0 to 20 K |
Mar 01 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Option Exercise | M | 36.05 | 3,200 | 115,360 | 125,010 | |
Mar 01 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 87.70 | 1,765 | 154,791 | 5,874 | 7.6 K to 5.9 K (-23.11 %) |
Mar 01 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 88.32 | 1,035 | 91,411 | 7,639 | 8.7 K to 7.6 K (-11.93 %) |
Mar 01 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 89.47 | 200 | 17,894 | 8,674 | 8.9 K to 8.7 K (-2.25 %) |
Mar 01 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Sell | S | 90.70 | 200 | 18,140 | 8,874 | 9.1 K to 8.9 K (-2.20 %) |
Mar 01 2018 | BPMC | Blueprint Medicine ... | Haviland Kate | Chief Business Offi ... | Buy | M | 36.05 | 3,200 | 115,360 | 9,074 | 5.9 K to 9.1 K (+54.48 %) |
Mar 01 2018 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Option Exercise | M | 28.36 | 10,000 | 283,600 | 134,000 | |
Mar 01 2018 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Sell | S | 87.69 | 1,106 | 96,985 | 0 | 1.1 K to 0 (-100.00 %) |
Mar 01 2018 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Sell | S | 88.40 | 8,794 | 777,390 | 1,106 | 9.9 K to 1.1 K (-88.83 %) |
Mar 01 2018 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Sell | S | 90.75 | 100 | 9,075 | 9,900 | 10 K to 9.9 K (-1.00 %) |
Mar 01 2018 | BPMC | Blueprint Medicine ... | McCain Tracey L | EVP and Chief Legal ... | Buy | M | 28.36 | 10,000 | 283,600 | 10,000 | 0 to 10 K |
Mar 01 2018 | BPMC | Blueprint Medicine ... | Demetri George | Director | Sell | S | 87.85 | 2,765 | 242,905 | 11,931 | 14.7 K to 11.9 K (-18.81 %) |
Mar 01 2018 | BPMC | Blueprint Medicine ... | Demetri George | Director | Sell | S | 88.45 | 3,085 | 272,868 | 14,696 | 17.8 K to 14.7 K (-17.35 %) |
Mar 01 2018 | BPMC | Blueprint Medicine ... | Demetri George | Director | Sell | S | 89.48 | 200 | 17,896 | 17,781 | 18 K to 17.8 K (-1.11 %) |
Mar 01 2018 | BPMC | Blueprint Medicine ... | Demetri George | Director | Sell | S | 90.68 | 200 | 18,136 | 17,981 | 18.2 K to 18 K (-1.10 %) |